StartupsPitchBook Newsabout 2 hours ago
Medtech VC Capital Concentrates in Large Deals
1 min read
Medtech VC deal value remains strong through Q3 2026, on pace to increase 3.4% despite declining deal counts. Capital concentrates in fewer, larger transactions, with surgical robotics and cardiovascular devices leading activity. Neko Health raised $700 million in July, while Precision Neuroscience secured $250 million in September.
Level
Hype check
Tap to vote and see what everyone thinks.
